Search Results 1471-1480 of 18896 for Insulin

  1. Health & Wellness - Page 642 of 772 - Mayo Clinic News Network

    Diabetes is a chronic condition that impairs the body's ability to regulate blood sugar due to inadequate insulin production. Producing insulin is a function of ...

  2. Pantoprazole (intravenous route) - Side effects & uses - Mayo Clinic

    Pantoprazole injection is used to treat certain conditions in which there is too much acid in the stomach. It is used to treat gastroesophageal reflux disease ( ...

  3. Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH) - Mayo Clinic

    ... insulin. Dose changes of these medications are allowed in the 6 months prior to diagnostic liver biopsy, except for GLP-1 agonists, which must remain on ...

  4. Health & Wellness - Mayo Clinic News Network

    November is Diabetes Awareness Month JACKSONVILLE, Fla. — Diabetes affects how the body uses glucose, also known as blood sugar. It can mean that there[...].

  5. A Study to Evaluate ALZT-OP1a in Subjects with Mild-to-Moderate Amyotrophic Lateral Sclerosis - Mayo Clinic

    Taking inhaled protein products on a chronic basis (such as insulin, parathyroid hormone [PTH], etc.). Subjects who weigh 88 lb (40 kg) or less, or, body ...

  6. A Study of Taxane, Trastuzumab, and Pertuzumab With or Without Atezolizumab in Treating Metastatic Breast Cancer Patients - Mayo Clinic

    Patients with controlled type 1 diabetes mellitus on a stable insulin regimen may be eligible;; Patients with eczema, psoriasis, lichen simplex chronicus of ...

  7. A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy - Mayo Clinic

    Patients with controlled Type 1 diabetes mellitus on a stable insulin regimen may be eligible for this study. Patients with eczema, psoriasis, lichen ...

  8. Publications - Eric Chen, M.D., Ph.D. - Mayo Clinic

    Immunohistochemical stains of proliferating cell nuclear antigen, insulin-like growth factor 2 and clusterin help distinguish malignant from benign liver ...

  9. A Study to Evaluate the Safety and Effectiveness of Axicabtagene Ciloleucel in Combination with Rituximab in Participants With Refractory Large B-Cell Lymphoma (ZUMA-14) - Mayo Clinic

    ... insulin regimen may be eligible for this study. History of deep vein thrombosis (DVT) or pulmonary embolism within the last 6 months. Any medical condition ...

  10. Dr. Andres Acosta Archives - Mayo Clinic News Network

    ... insulin efficiency or actually generate signals that cause cells to die. “Imagine a pool filled with thousands of gallons of water,” says Dr. Jensen. “A ...